VINZENZ GRUPPE
     
 

Radio-Onkologie und Strahlentherapie

Exportieren als [RSS2 feed] RSS
Gruppieren nach: Datum | Typ des Eintrags | Creators Browse ID
Anzahl der Einträge: 5.

Artikel

Geinitz, Hans, Silberberger, Elisabeth, Spiegl, Kurt, Feichtinger, Johann, Wagner, Helga, Hermann, Philipp, Bräutigam, Elisabeth, Track, Christine, Weis, Eva Maria, Venhoda, Clemens, Huppert, Roswitha, Spindelbalker-Renner, Barbara, Zauner-Babor, Georgine, Nyiri, Dalma Viktoria, Karasek, Nicola, Erdei, Mercedesz, Gheju, Ruben, Gruber, Georg, Egger, Margot und Dieplinger, Benjamin (2024) SARS-CoV-2 vaccination willingness and humoral vaccination response in radiation oncology patients. Vaccine, 42 (4). pp. 945-959. ISSN 1873-2518 Item not available from this repository.

Lilleby, Wolfgang, Kishan, Amar und Geinitz, Hans (2024) Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancer. World journal of urology, 42 (1). p. 41. ISSN 1433-8726 Item not available from this repository.

Fachpublikation (peer reviewed)

Zehentmayr, Franz, Feurstein, Petra, Ruznic, Elvis, Langer, Brigitte, Grambozov, Brane, Klebermass, Marisa, Hüpfel, Herbert, Feichtinger, Johann, Minasch, Danijela, Heilmann, Martin, Breitfelder, Barbara, Steffal, Claudia, Gastinger-Grass, Gisela, Kirchhammer, Karoline, Kazil, Margit, Stranzl, Heidi und Dieckmann, Karin (2024) Durvalumab impacts progression-free survival while high-dose radiation >66 Gy improves local control without excess toxicity in unresectable NSCLC stage III: Real-world data from the Austrian radio-oncological lung cancer study association registry (ALLSTAR). Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 196. p. 110294. ISSN 1879-0887
[thumbnail of Feichtinger Durvalumab impacts progression free survival while high-dose radiation 66 Gy improves local control without excess toxicity in unresectable NSCLC stage III Elsevier 2024.pdf]
Vorschau

Haderlein, Marlen, von der Grün, Jens, Balermpas, Panagiotis, Rödel, Claus, Hautmann, Matthias G, Steger, Felix, Bohr, Christopher, Hehr, Thomas, Stromberger, Carmen, Budach, Volker, Schymalla, Markus, Engenhart-Cabillic, Rita, Kocik, Lukas, Geinitz, Hans, Nestle, Ursula, Klautke, Gunter, Scherl, Claudia, Gall, Christine, Frey, Benjamin, Schubert, Philipp, Semrau, Sabine, Ott, Oliver, Kesting, Marco, Iro, Heinrich, Mueller, Sarina K und Fietkau, Rainer (2024) De-intensification of postoperative radiotherapy in head and neck cancer irrespective of human papillomavirus status-results of a prospective multicenter phase II trial (DIREKHT Trial). Frontiers in oncology, 14. p. 1447123. ISSN 2234-943X
[thumbnail of Haderlein DIREKHT Studie Front Oncol 2024.pdf]
Vorschau

Pichler, Josef, Traub-Weidinger, Tatjana, Spiegl, Kurt, Imamovic, Larisa, Braat, Arthur J A T, Snijders, Tom J, Verhoeff, Joost J C, Flamen, Patrick, Tauchmanova, Libuse, Hayward, Colin und Kluge, Andreas (2024) Results from a phase I study of 4-<i>l</i>-[131I]iodo-phenylalanine ([<sup>131</sup>I]IPA) with external radiation therapy in patients with recurrent glioblastoma (IPAX-1). Neuro-oncology advances, 6 (1). vdae130. ISSN 2632-2498
[thumbnail of Pichler Results from a phase I study IPAX-1 Neurooncol Advanc 2024.pdf]
Vorschau

Diese Liste wurde am Thu Jun 5 03:01:23 2025 UTC generiert.